Addressing buprenorphine supply barriers: A guidance commentary
The current supply-side constraints limiting buprenorphine availability at pharmacies may reduce the potential impact of recent initiatives to improve medications for opioid use disorder (MOUD) access. The recent opioid litigation combined with existing federal regulation and enforcement has resulte...
Saved in:
Published in | Journal of the American Pharmacists Association Vol. 64; no. 2; pp. 377 - 379 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!